生物股份
(600201)
| 流通市值：127.70亿 | | | 总市值：127.70亿 |
| 流通股本：11.00亿 | | | 总股本：11.00亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 | 1,042,405,531.87 |
| 营业总成本 | 612,971,608.14 | 269,670,737.42 | 1,278,271,814.19 | 907,899,347.17 |
| 其他经营收益 | | | | |
| 营业利润 | 130,734,736.52 | 97,538,962.66 | 104,771,240 | 179,319,295.91 |
| 利润总额 | 130,629,378.54 | 96,686,207.01 | 104,619,896.61 | 179,163,766.88 |
| 净利润 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 | 159,198,803.05 |
| 每股收益 | | | | |
| 其他综合收益 | -2,284.37 | -1,188.9 | 60,380,493.99 | 95,422,007.86 |
| 综合收益总额 | 111,426,237.32 | 81,697,351.83 | 155,886,803.31 | 254,620,810.91 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,823,600,134.56 | 2,375,140,038.79 | 2,343,742,348.27 | 2,508,564,241.66 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,793,170,656.01 | 4,161,795,416.65 | 4,267,829,898.78 | 4,225,902,713.75 |
| 资产总计 | 6,616,770,790.57 | 6,536,935,455.44 | 6,611,572,247.05 | 6,734,466,955.41 |
| 流动负债: | | | | |
| 流动负债合计 | 670,177,905.05 | 648,311,888.37 | 720,530,437.02 | 729,802,631.73 |
| 非流动负债: | | | | |
| 非流动负债合计 | 420,605,880.15 | 324,564,981.89 | 340,180,576.68 | 351,909,464.23 |
| 负债合计 | 1,090,783,785.2 | 972,876,870.26 | 1,060,711,013.7 | 1,081,712,095.96 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,411,031,288.79 | 5,461,324,776.38 | 5,368,046,822.74 | 5,468,925,887.67 |
| 股东权益合计 | 5,525,987,005.37 | 5,564,058,585.18 | 5,550,861,233.35 | 5,652,754,859.45 |
| 负债和股东权益合计 | 6,616,770,790.57 | 6,536,935,455.44 | 6,611,572,247.05 | 6,734,466,955.41 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 669,771,958.43 | 280,107,972.38 | 1,491,582,223.12 | 1,077,694,352.98 |
| 经营活动现金流出小计 | 618,748,108.46 | 268,700,017.53 | 1,175,465,363.02 | 886,068,992.23 |
| 经营活动产生的现金流量净额 | 51,023,849.97 | 11,407,954.85 | 316,116,860.1 | 191,625,360.75 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 725,429,624.86 | 513,834,646.24 | 521,557,492.74 | 266,150,943.66 |
| 投资活动现金流出小计 | 683,326,662.69 | 478,858,503.16 | 727,410,324.62 | 156,189,248.74 |
| 投资活动产生的现金流量净额 | 42,102,962.17 | 34,976,143.08 | -205,852,831.88 | 109,961,694.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 100,870,600 | - | 10,702,670 | 8,486,670 |
| 筹资活动现金流出小计 | 213,539,554.52 | 71,697,278.99 | 318,145,960.58 | 266,746,462.77 |
| 筹资活动产生的现金流量净额 | -112,668,954.52 | -71,697,278.99 | -307,443,290.58 | -258,259,792.77 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -19,542,142.38 | -25,313,181.06 | -197,179,262.36 | 43,327,262.9 |
| 期末现金及现金等价物余额 | 597,202,968.78 | 591,431,930.1 | 616,745,111.16 | 857,251,636.42 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -19,542,142.38 | - | -197,179,262.36 | - |
最新报告期：2026-08-05| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 王思洋,龙友琪 | 0.20 | 0.24 | -- | 2026-08-05 |